Zhang Ran, Zong Jiaojiao, Peng Yanfei, Shi Jiandang, Du Xiaoling, Liu Haitao, Shen Yongmei, Cao Jiasong, Jia Bona, Liu Feng, Zhang Ju
Department of Biochemistry and Molecular Biology, College of Life Sciences, Bioactive Materials Key Lab of Ministry of Education, Nankai University, Tianjin, China.
Shandong Provincial Key Laboratory of Radiation Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
J Cell Biochem. 2021 May 3. doi: 10.1002/jcb.29938.
Cancer-associated fibroblasts (CAFs) can promote the development and metastasis of prostate cancer partly by mediating tumor-associated inflammation. An increasing amount of studies have focused on the functional interactions between CAFs and immune cells in the tumor microenvironment (TME). We previously reported that G protein-coupled receptor 30 (GPR30) was highly expressed in prostate CAFs and plays a crucial role in prostate stromal cell activation. However, the effect and underlying mechanism of GPR30 expression in prostate CAFs affecting the interaction between CAFs and tumor-associated macrophages (TAMs) need further elucidation. Here, we found that, compared with CAF-shControl, CAF-shGPR30 inhibited macrophage migration through transwell migration assays, which should be attributed to the decreased expression of C-X-C motif chemokine ligand 12 (CXCL12). In addition, macrophages treated with a culture medium of CAF-shGPR30 exhibited attenuated M2 polarization with downregulated M2-like markers expression. Moreover, macrophages stimulated with a culture medium of CAF-shGPR30 were less efficient in promoting activation of fibroblast cells and invasion of PCa cells. Finally, cocultured CAF-shGPR30 and macrophages suppressed PCa cell invasion compared to cocultured CAF-shControl and macrophages by decreasing interleukin-6 (IL-6) secretion, and this effect could be abrogated with rescue expression of IL-6. Our results pinpoint the function of GPR30 in prostate CAFs on regulating the CAF-TAM interaction in the TME and provide new insights into PCa therapies via regulating TME.
癌症相关成纤维细胞(CAFs)可部分通过介导肿瘤相关炎症促进前列腺癌的发展和转移。越来越多的研究聚焦于肿瘤微环境(TME)中CAFs与免疫细胞之间的功能相互作用。我们之前报道过,G蛋白偶联受体30(GPR30)在前列腺CAFs中高表达,并在前列腺基质细胞激活中起关键作用。然而,前列腺CAFs中GPR30表达影响CAFs与肿瘤相关巨噬细胞(TAMs)相互作用的效应及潜在机制尚需进一步阐明。在此,我们发现,与CAF-shControl相比,CAF-shGPR30通过Transwell迁移实验抑制巨噬细胞迁移,这应归因于C-X-C基序趋化因子配体12(CXCL12)表达降低。此外,用CAF-shGPR30培养基处理的巨噬细胞表现出M2极化减弱,M2样标志物表达下调。而且,用CAF-shGPR30培养基刺激的巨噬细胞促进成纤维细胞激活和前列腺癌细胞侵袭的效率较低。最后,与共培养的CAF-shControl和巨噬细胞相比,共培养的CAF-shGPR30和巨噬细胞通过减少白细胞介素-6(IL-6)分泌抑制前列腺癌细胞侵袭,并且这种效应可通过IL-6的拯救表达而消除。我们的结果明确了GPR30在前列腺CAFs中对调节TME中CAF-TAM相互作用的功能,并为通过调节TME进行前列腺癌治疗提供了新的见解。